Obstetrical management of fetal alloimmune thrombocytopenia
10.3760/cma.j.cn113903-20200601-00518
- VernacularTitle:胎儿同种免疫性血小板减少症的产科管理进展
- Author:
Ping LI
;
Xi YUAN
;
Weishe ZHANG
;
Yanhua ZHAO
- From:
Chinese Journal of Perinatal Medicine
2021;24(1):65-70
- CountryChina
- Language:Chinese
-
Abstract:
Fetal alloimmune thrombocytopenia (FAIT) is a severe perinatal complication, which can seriously affect fetal development, and may even lead to intrauterine hemorrhage and intrauterine death. There are controversies in the clinical diagnosis and treatment of the disease due to its low incidence and limited treatment experience. This paper reviews the progress to date in understanding the condition, incidence, screening of high-risk factors, prenatal and delivery management of FAIT based on domestic and foreign guidelines, in order to help obstetricians in the clinical management of FAIT.